The Section of Hepatopancreatobiliary (HPB) Surgery is dedicated to patient care, education, and research of all conditions of the liver, biliary system, and pancreas. In addition, our faculty are actively involved in the treatment of other GI malignancies, including gastric cancer, carcinoid tumors of the GI tract, gastrointestinal stromal tumors, abdominal soft tissue sarcomas, and peritoneal surface malignancies.
A nationally ranked cancer program, Duke is consistently recognized as among the best cancer programs in the country by U.S.News & World Report. We are a top program in pancreatic resection volume. We are an approved National Pancreas Foundation Center for pancreas cancer. We are a regional referral center for complex liver resection and soft tissue sarcoma.
We offer novel surgical approaches for these patients, including laparoscopic and robotic pancreatic and liver resection. We also offer novel treatment strategies, including ablation and regional perfusion strategies.
Through ongoing research, we work to discover, evaluate, and implement novel therapies. We work closely with gastroenterologists, imaging specialists, and cancer experts to determine the best course of treatment for each patient. Nearly every cancer patient’s case is discussed in a multidisciplinary tumor board in order to assure the highest-quality care and decision making for each patient.